[Implantable cardioverter defibrillator does not eliminate need for antiarrhythmic drugs in secondary prevention of life threatening ventricular arrhythmias. Results of OPTIC trial].
Iavelov
I S
IS
D000638:Amiodarone / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D017147:Defibrillators, Implantable; D004554:Electric Countershock / Q000295:instrumentation*; D005260:Female; D006301:Health Services Needs and Demand; D006801:Humans; D008297:Male; D013015:Sotalol / Q000627:therapeutic use*; D016896:Treatment Outcome; D014693:Ventricular Fibrillation / Q000503:physiopathology* / Q000517:prevention & control / Q000628:therapy*
D000889:Anti-Arrhythmia Agents; D013015:Sotalol; D000638:Amiodarone